Related Experiment Video
Updated: Sep 19, 2026

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
Published on: February 17, 2023
Characteristics of Low-Voltage Zones in Patients With Heart Failure With Preserved Ejection Fraction
Shuntaro Tamura1, Yosuke Nakatani2, Jin Soga3
1Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
Background:
Atrial fibrillation (AF) frequently coexists with heart failure with preserved ejection fraction (HFpEF), and low-voltage zones (LVZs) in the atria represent atrial remodeling. However, the impact of HFpEF on the extent and distribution of LVZs and ablation outcomes remains unknown.
Objective:
To characterize LVZs in patients with HFpEF undergoing AF ablation and evaluate their association with arrhythmia recurrence.
Methods:
A total of 128 consecutive patients (66±12 years) who underwent AF ablation for the first time were retrospectively analyzed. HFpEF was defined as a left ventricular ejection fraction >50% with a history of heart failure treatment or an HFA-PEFF score ≥5. Meanwhile, LVZs were defined as bipolar voltage <0.5 mV and quantified across five left atrial regions.
Results:
Forty-seven patients (36.7%) were diagnosed with HFpEF. LVZs were significantly more extensive in the overall left atrium in the HFpEF group (16.3±13.5 vs. 8.2±7.6 cm2, p < 0.001), with the greatest difference being observed in the anterior wall (5.6±5.4 vs. 2.3±2.8 cm2, p < 0.001). During 9±4 months, arrhythmia recurrence rates did not differ significantly between HFpEF and non-HFpEF groups (12.8% vs. 13.6%, p = 0.310). Posterior wall isolation was more frequently performed in the HFpEF group (27.6% vs. 4.9%, p < 0.001). In multivariable analysis, HFpEF, age, and persistent AF were independent determinants of LVZ extent.
Conclusions:
AF patients with HFpEF exhibit more extensive LVZs, indicating advanced atrial remodeling. Despite differences in atrial substrate and ablation strategy, arrhythmia recurrence rates were comparable between patients with and without HFpEF.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure Drugs: Inotropic Agents
